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Abstract
Background—Peanut oral immunotherapy (PNOIT) induces persistent tolerance to peanut in a 
subset of patients and induces specific antibodies which may play a role in clinical protection. The 
contribution of induced antibody clones to clinical tolerance in PNOIT is unknown, however.
Objective—We hypothesized that PNOIT induces a clonal, allergen-specific B cell response, 
which could serve as a surrogate for clinical outcomes.
Methods—We used a fluorescent Ara h 2 multimer for affinity-selection of Ara h 2-specific B 
cells, and subsequent single cell immunoglobulin amplification. Diversity of related clones was 
evaluated by next-generation sequencing (NGS) of immunoglobulin heavy chains from circulating 
memory B cells using 2×250 paired-end sequencing on the Illumina MiSeq platform.
Results—Expression of class-switched antibodies from Ara h 2 positive cells confirms 
enrichment for Ara h 2 specificity. PNOIT induces an early and transient expansion of circulating 
Ara h 2 specific memory B cells that peaks at week 7. Ara h 2-specific sequences from memory 
cells have rates of non-silent mutations consistent with affinity maturation. The repertoire of Ara h 
2-specific antibodies is oligoclonal. NGS-based repertoire analysis of circulating memory B cells, 
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reveals evidence for convergent selection of related sequences in 3 unrelated subjects, suggesting 
the presence of similar Ara h 2-specific B cell clones.
Conclusions—Using a novel affinity selection approach to identify antigen-specific B cells, we 
demonstrate that the early PNOIT induced Ara h 2-specific BCR repertoire is oligoclonal, 
somatically hypermutated and shares similar clonal groups among unrelated individuals consistent 
with convergent selection.
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Introduction
IgE-mediated peanut allergy is one of the most serious food allergies due to its persistence 
and strong association with severe reactions, such as anaphylaxis.1, 2 In clinical trials, peanut 
oral immunotherapy (PNOIT) can significantly shift the threshold dose of peanut that can be 
ingested without symptoms in the majority of allergic patients through a gradual, 
incremental increase in oral peanut exposure under careful observation. The durability of 
this protective clinical effect once regular antigen administration ceases is highly variable 
however -- some individuals become more sensitive over time, while others appear to have 
long-lasting protection.3 A number of cellular and humoral immune responses have been 
associated with PNOIT and other forms of immunotherapy, including the suppression of 
mast cell and basophil reactivity to allergen, the deletion of Th2-skewed CD4 T cells, the 
induction of regulatory T cell populations and the induction of antigen-specific antibodies, 
including IgG, IgG4, and IgA.4-7 While many of these immune responses have been 
documented, few have been significantly or consistently correlated with clinical outcomes. 
In egg OIT, basophil suppression was correlated with the clinical effect immediately 
following therapy, but not with lasting protection.8 Demonstration of ‘blocking antibodies’ – 
capable of inhibiting IgE-mediated responses – first came more than 50 years ago in the 
context of subcutaneous allergen immunotherapy9-11, and such functional measures of 
antigen-specific antibody have correlated better with clinical outcomes than the 
concentration of antigen-binding antibodies in several studies.12, 13
Previous work comparing pre- and post-PNOIT serum from patients who underwent 
successful PNOIT demonstrated the development of epitope spreading within the IgE and 
IgG/IgG4 compartments to specific peanut antigens, suggesting that immunotherapy may 
increase the pool of cells producing specific antibodies.14 The emergence of new antigen-
specific clones must be accomplished by the stimulation and expansion of a pool of B cells 
that has not yet terminally differentiated to secrete antibodies and retains the capacity to 
undergo BCR diversification, class switching and phenotypic differentiation. Further 
elucidation of the functional role of these cells – and therefore their mechanistic 
contributions of humoral immunity to OIT – has been limited by technical hurdles, however. 
One way to address the potential functional relevance of such OIT-induced changes is to 
isolate antigen-specific B cells and study them on a clonal level.
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We hypothesized that we could recover peanut allergen-specific B cells from OIT patients 
using an affinity selection approach and that this method could be complemented with NGS-
based analysis of the BCR repertoire to study antigen-specific responses. We focused on the 
allergen Ara h 2, as recent clinical studies have suggested that an Ara h 2-specific IgE 
response is most predictive of clinical hypersensitivity.15, 16 Using a fluorescent Ara h 2 
multimer, we identified, enumerated and isolated allergen-specific B cells in patients 
undergoing PNOIT. Single-cell BCR cloning and expression was used to validate the 
affinity selection approach. Complementing this approach with NGS-based analyses of the 
memory BCR pool allowed us to more globally characterize the Ara h 2-specific BCR 
repertoire during PNOIT over time in three peanut allergic individuals.
Methods
Peanut oral immunotherapy trial
Peripheral blood was obtained after IRB-approved consent from peanut allergic participants 
of an open-label randomized trial of peanut OIT (NCT01324401). These study participants 
were 7-21 years old with a diagnosis of peanut allergy based on a clinical history of reaction 
to peanut within one hour of ingestion and either a positive skin prick test (>8 mm wheal) or 
elevated peanut-specific IgE (CAP FEIA >10 kU/L). The study schema, including time 
points of blood sampling, is shown in Figure 2.
Multimer preparation
Purified native Ara h 2 (gift from Stef Koppelman) was biotinylated at lysine residues using 
a water-soluble biotin-XX sulfosuccinimidyl ester (Invitrogen). Fluorescent multimers were 
formed using stepwise addition of Alexa Fluor 488 streptavidin (Invitrogen) to biotinylated 
Ara h 2 proteins until a 1:4 molar ratio was reached. The multimer was stored in the dark at 
4°C until use.
Identification of Arah2+ circulating B cells
Peripheral blood mononuclear cells (PBMCs) were isolated by means of density gradient 
centrifugation (Ficoll-Paque Plus; GE Healthcare) from peripheral blood. These cells were 
then stained using CD3-APC (eBioscience clone OKT3), CD14-APC (eBioscience, clone 
61D3), CD16-APC (eBioscience clone CB16), CD19-APC-Cy7 (BD Biosciences clone 
SJ25C1), CD27-PE (BD Pharmingen clone M-T271), CD38-Violet 421 (BD Biosciences 
clone HIT2), IgM-PE-Cy5 (BD Pharmingen clone G20-127), and AF488- Ara h 2 multimer. 
Normalization of AF488 was performed using Quantum Alexa Fluor 488 Molecules of 
Equivalent Soluble Fluorochrome (MESF) Beads (Bangs Laboratories, Inc). Flow cytometry 
was performed with an LSR II instrument (BD Biosciences). Data were analyzed using 
FlowJo 8.8.7 software (TreeStar). Experimental data was excluded from those samples 
which failed to meet quality control criteria; for example, samples with high background in 
the negative control (stained with the entire panel except for the Ara h 2 multimer) defined 
as >50 events per million CD19+ cells in the gate for multimer-positive cells were excluded 
(1.4% of 140 samples).
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Single cell RT-PCR and immunoglobulin gene amplification
After using a similar staining procedure as above with PBMCs isolated from a PNOIT 
patient, single Arah2+CD19+ B cells were sorted using BD fluorescence-activated cell 
sorter Aria II into a 96-well plate (Eppendorf) containing 10uL of first strand buffer 
(Invitrogen) and 20 U Recombinant RNasin® Ribonuclease Inhibitor (Promega), and were 
subsequently frozen at -80°C. The following nested RT-PCR protocol was adapted from 
previous papers.17-19 The cells underwent heat lysis (65°C for 10 minutes, 25°C for 3 
minutes, then 4°C) along with incubation with 3uL of NP40, and 150ng of random 
hexamers. The RT reaction was performed with first strand buffer (Invitrogen), 0.1mM DTT 
(Invitrogen), 2.5mM dNTP (Invitrogen), and SuperScript III Reverse Transcriptase 
(Invitrogen). During the subsequent 2 PCR amplification rounds, in the first round, 5uL of 
template was used along with Taq DNA polymerase (Invitrogen), and the second nested 
PCR used 3uL of template along with Pfu DNA polymerase (Invitrogen). Primers for both 
rounds of PCR were modified from the previously published primer sets.18 The products 
from the second PCR were run on a 1.5% agarose gel to determine if heavy and light chains 
were successfully amplified (Figure E1). Successfully amplified products were Sanger 
sequenced (Genewiz Inc.) using second PCR primers. Consensus sequences combining both 
the forward and reverse sequences were determined using pairwise alignment in Geneious 
(Biomatters Ltd). These sequences were then analyzed using IMGT/V-BLAST,20-22 to 
identify germline V, D, and J sequences with the highest identity, CDR3 regions, and 
nucleotide and amino acid changes from germline sequence. Inference of antigen selection 
was performed using the Immunoglobulin Analysis Tool.23
Recombinant antibody production
Twenty-seven paired heavy and light chains were selected after sequencing as above. DNA 
from the second nested PCR of these heavy and light chains were purified using Qiaquick® 
96 PCR Purification Kit (Qiagen). A third PCR added restriction enzyme sites to the purified 
PCR product,17 followed by purification again using Qiaquick® 96 PCR Purification Kit. 
Restriction enzyme digestion with AgeI, BsiWI, Sall and XhoI (New England Biolabs) was 
prepared for ligation with linearized vectors containing human IgG1, kappa, or lamda 
constant domains, respectively (gift from Michel Nussenzweig). Competent E. coli NEB5α 
bacteria (New England Biolabs) were transformed at 42 °C (30 s) with the ligation produ ct, 
grown for 1.5 hours at 37°C, followed by selection on LB plates with 100ug/mL ampicillin. 
Ampicillin-resistant clones were selected and screened for vector insertion with colony PCR 
using forward and reverse primers19 followed by gel electrophoresis of PCR products on a 
1% agarose gel. Plasmid DNA from overnight liquid cultures (LB with 100ug/mL 
ampicillin) of selected colonies which contained vectors was obtained using QIAprep Spin 
Miniprep Kit (Qiagen). Plasmid DNA was sequenced using colony PCR primers to 
determine similarity to previous sequences in Geneious using pairwise alignment). Plasmid 
DNA (25ng) from selected heavy and light chains were transfected into HEK293 T cells 
using GenJet™ In Vitro DNA Transfection Reagent (SignaGen). Supernatants were 
harvested from cells after three days of culture at 37°C with 5% CO2 in serum free HL-1 
media (Lonza) supplemented with Pen-Strep and 8mM Glutamax (Gibco).
Patil et al. Page 4
J Allergy Clin Immunol. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Recombinant antibody characterization
Commercial ELISA assays (ImmunoCAP, Phadia) and protein microarrays validated the 
Ara h 2 specificity of the recombinant antibodies. Quantification of IgG antibodies was also 
validated using a cytometric bead assay (BD™ Cytometric Bead Array).
Next generation BCR sequencing
Ten to twenty million cryopreserved PBMCs from week 2 and week 14 during PNOIT were 
selected from three PNOIT patients in whom single-cell immunoglobulin amplification had 
been performed. Immunomagnetic peripheral memory B cells were isolated using Human 
Memory B Cell Enrichment Cocktail (Stemcell Technologies) with CD19+ negative 
selection followed by CD27+ selection using the manufacturers' directions. Cells were lysed 
in RLT buffer (Qiagen) supplemented with 1% β-mercaptoethanol (Sigma). RNA was 
isolated using QIAquick EasyRNA Plus Purification kits (Qiagen), and one-fifth of the RNA 
was used for RT-PCR, using a previously published protocol.24 Briefly, cDNA was 
synthesized using Superscript III Reverse Transcriptase (Invitrogen) and five constant 
region reverse transcriptase primers along with SUPERase-ln (Ambion). At the completion, 
RNAse H (Invitrogen) was used before PCR. Each of the eleven PCR reactions using 
Platinum Taq DNA Polymerase High Fidelity (Invitrogen) contained 2μL of cDNA, primers 
for the five constant regions, and a separate leader region primer. PCR product purification 
was performed using Ampure Purification with a bead:product ratio of 1.8:1. Concentration 
and DNA quality was assessed by Bioanalyzer (Agilent) before sequencing. Commercial 
library preparation and sequencing services were used (Genewiz) for lllumina library 
preparation of 100ng cDNA (NEBNext Ultra DNA Library Preparation, New England 
BioLabs) followed by lllumina MiSeq 2×250 sequencing.
Analysis of next generation sequencing data
The next generation sequencing data analysis pipeline is detailed in the supplement (Figures 
E2-E3, Table E1). Forward and reverse read quality for each sample was examined using 
FastQC (Babraham Bioinformatics). SeqPrep (https://github.com/jstjohn/SeqPrep) was used 
to merge paired reads and trim lllumina adapters. Merged reads were filtered to a minimum 
length of 300bp. Sequences with a >99% homology were collapsed as unique reads.25 
Sequence orientation and isotype determination was performed using leader sequence and 
constant region primer alignment allowing for 1 and 2 mismatches respectively. These 
sequences were then analyzed using IMGT/High V-QUEST26,27 to identify germline V, D, 
and J sequences with the highest identity, CDR3 regions, and nucleotide and amino acid 
changes from germline sequence. Python (http://www.python.org) and R (R Foundation for 
Statistical Computing)28 scripts used in the analysis are available on request.
Statistical Analysis
For longitudinal analysis, the time period was recoded as eight groups with approximately 
15 observations per group (Table E2). The last group was dropped because of sparse data. In 
order to take into account the repeated aspect of the design, the reported means are least 
squares means from a linear mixed model. The relation between biomarkers and time was 
modeled using a generalized additive mixed model, which takes into account the non-linear 
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relationship between variables and outcome and the longitudinal aspect of the design. The 
models were fitted using the mgcv29 packages in R (R Foundation for Statistical 
Computing),28 the appropriate degrees of freedom for the smoothers were selected 
automatically using cross validation. Circos was used to make circular diagrams.30
Results
Ara h 2 multimer is specific
To validate the specificity of this reagent, we stained PBMCs with the Ara h 2 multimer 
(Figure 1, A) and analyzed basophils (CD123+CD203c+), which express high surface levels 
of bound IgE. We passively sensitized basophils from a non-peanut allergic donor with 
serum from an allergic (with Ara h 2 specific IgE) or non-allergic donor and stained those 
cells with multimer to demonstrate that only basophils sensitized with serum containing Ara 
h 2-specific IgE were fluorescent (Figure 1, B). Circulating basophils from patients 
undergoing PNOIT (N=19) had a significant shift in their fluorescence when stained with 
multimer, compared to healthy controls (N=5, P=0.05, Figure 1, C). Allergic subjects also 
had elevated levels of Ara h 2-specific IgE as measured by ImmunoCAP.
PNOIT increases the frequency of circulating multimer-positive memory B cells and 
specific immunoglobulins
To identify Ara h 2-specific B cells within each B cell subset, we stained PBMCs with the 
multimer (Figure 1, D). For comparison between samples, we used the frequency of 
multimer-positive cells per million CD19+ B cells or per million class switched memory B 
cells. Figure 2 outlines the PNOIT study design. We found that the frequency of circulating 
Arah2-specific, class-switched memory B cells transiently increased after the initiation of 
PNOIT, by 3.2 fold within the entire CD19+ B cell population (P=0.06) and by 3.8 fold 
within the class-switched memory B cell population (P=0.03). This induction of multimer-
positive memory B cells peaked around 7 weeks after the initiation of PNOIT (Figure 3, A). 
There was a similar trend of similar magnitude, though not statistically significant because 
of small numbers, in the plasmablast population. There was also a significant decrease at the 
end of PNOIT in the Arah 2 -positive naïve B cell population, both within the entire CD19+ 
B cell population (66% decrease, P=0.02) and within the naïve B cell compartment (80% 
decrease, P<0.01) (Figure 3, B).
As seen in previous studies of PNOIT, Ara h 2-specific IgE levels transiently increased 
during early PNOIT, peaking at nearly double the starting value about seven weeks after the 
start of PNOIT and remained elevated above baseline until after week 35 (P<0.005). The 
Ara h 2-specific IgA, IgG, and IgG4 levels also rose significantly above baseline by week 7 
and continued to rise through PNOIT (P<0.005, Figure 3, C).
Ara h 2 positive, class-switched B cells express highly mutated, Ara h 2-specific BCRs
One month after beginning PNOIT in three unrelated subjects, 159 multimer-positive 
CD19+ B cells were sorted individually (Figure 4, A). Single-cell immunoglobulin by RT-
PCR amplification yielded 135 heavy chains and 99 light chains (yield of 74%); nucleotide 
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sequences were obtained by Sanger sequencing. Of these, there were 88 paired heavy and 
light chains from single cells.
Of the 135 cloned immunoglobulin heavy chain sequences from multimer-positive B cells, 
40% were IgM, 32.6% were IgG, 26.7% were IgA and <1% could not be accurately 
classified (Figure 4, B). As expected, the frequency of somatic mutations in the IgA and IgG 
heavy chain sequences was higher than that among IgM heavy chain sequences (Figure 4, 
C). This result was particularly true of mutations causing coding changes: the frequency of 
non-silent mutations in the heavy chain complementarity-determining regions (CDR) was 
significantly higher than in the framework regions (FR) of the IgA and IgG sequences (25 
vs. 15.8, P=0.02 and 25 vs. 13.2, P<0.001) than IgM sequences (0 vs. 0, P=0.28) (Figure 
4D). The heavy chain sequences from all 3 patients used a variety of V and J gene segments 
with the most abundant combination being V3-J4 (Figure 4, E).
To produce recombinant antibodies, we selected productive paired heavy and light chains, 
defined by IMGT analysis,26 from the single cell amplification of Ara h 2-positive B cells. 
A total of 27 antibodies were produced from the cloned IgA and IgG sequences, with three 
from the first patient, three from the second patient, and twenty-one from the third patient.
Of these antibodies, 24/27 (89%) were specific for Ara h 2 when characterized by 
ImmunoCAP (Table 2, Figure 4, F).
Ara h 2-specific responses are oligoclonal
We addressed the question of related clonal diversity of the 135 affinity selected BCR heavy 
chain (IgH) library by examining the CDR3 regions of sequences sharing the same V-J gene 
usage. If the amino acids in the CDR3 region were the same or differed by 2 or fewer amino 
acids, the sequences were grouped as highly related, most likely arising from the same 
parent clone and therefore referred to as a clonal group. Among the representative Ara h 2-
specific sequences, a total of 10 clonal groups were identified (Table 2), capturing 18% of 
sequences (Figure E4). Half of these clonal groups included both IgA and IgG sequences, 
consistent with the likelihood that sequences in this group derive from a shared ancestral 
clone that differentiated to both IgA and IgG isotypes. Figure E5 shows the number and 
distribution of sequences that appeared as related or unique clones.
Of note, within these heavy chain clonal groups, several of the paired light chains were 
distinct from each other, suggesting that light chain promiscuity may exist in the Ara h 2-
specific antibodies.
Stereotyped Ara h 2-specific clones present between unrelated individuals
To further analyze the antigen-specific B cell repertoire of these patients, next generation 
sequencing (NGS) of the BCR heavy chains from isolated CD19+CD27+ B cells was 
performed at two time points (weeks 2 and 14) before and after the peak induction of Ara h 
2-specific memory B cells observed by flow cytometry (Figure 3). We used the 135 IgH 
sequences of Ara h 2-specific single B cells described above to identify clonal groups (same 
V and J segment usage and a CDR3 ≤ 2 amino acid substitutions) within the sequenced 
repertoires.
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A total of 46 clonal groups (relating to 34% of the 135 IgH sequences) were identified by 
this definition. The number of clonal groups varied between patients (5 from patient 1, 7 
from patient 2, 34 from patient 3). The number of homologous corresponding NGS 
sequences within each clonal group varied between 1 and 187 (median 13.5).
Similar to the IgH sequences identified by affinity selection, the homologous sequences 
from the NGS library within the IgG and IgA compartments had undergone high rates of 
somatic hypermutation (Figure 6).
Visualization of these clonal groups (Figure 5) within the NGS repertoire highlights an 
apparent convergence in selection between individuals. These stereotyped clones between 
individuals are extensively homologous and share non-germline encoded amino acids not 
only within the CDR3 but at CDR1 and 2 as well (Figure 6, B).
Discussion
Previous clinical PNOIT studies have reproducibly demonstrated that antigen-specific 
immunoglobulins change during the course of PNOIT; however, further investigation of 
clonal antigen-specific responses to immunotherapy has been technically limited by our 
inability to reliably detect the low frequency population of antigen-specific B cells.
In this paper, we demonstrated the use of a novel fluorescent Ara h 2 multimer to identify 
Ara h 2-specific class-switched memory B cells by BCR affinity. Previous efforts to identify 
allergen-specific cells used several approaches such as transformation of circulating B cells 
using various activating stimuli31-33 and fluorescently labeled monomeric antigens,34, 35 
though low fluorescence and nonspecific binding of B cells can result in a poor signal-to-
noise ratio when compared with fluorescent antigen multimers.36
We further confirmed the approach by expressing Ara h 2 antibodies from sorted multimer-
positive B cells and testing their specificity. We focused on the peanut antigen Ara h 2 due 
to its clinical relevance and importance in the function of allergic effector cells, but this 
approach should prove feasible to study B cell responses to other allergens as well. Using 
this technology, we have shown that a transient indication of circulating allergen specific B 
cells occurs early in peanut oral immunotherapy.
The kinetics of the induced antigen-specific memory B cell population demonstrates that the 
rise in Ara h 2-specific IgA, IgG, and IgG4 begins at about the same time as the peak 
expansion of this population – around week 7. Antigen-specific immunoglobulin induction 
has been reproduced in several trials of peanut immunotherapy.4, 7 Recent work using a 
peptide microarray-based assay suggests that antigen-specific antibody diversification also 
occurs in peanut immunotherapy.14 The induction of the Ara h 2 specific B cells found here 
is consistent with that observation. The early and transient increase in allergen-specific IgE 
during PNOIT occurs on a similar kinetic time scale as the expansion in the memory B cell 
population. The increase in epitope diversity described in the work by Vickery, et.al., 14 is 
another interesting avenue worth further exploration, as the increase in allergen-specific 
memory B cells may contribute to the expansion of this secreted allergen-specific IgE pool, 
and further phenotyping of this population may prove to be interesting in understanding 
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some aspects of allergen-specific IgE memory. The frequency of antigen-specific B cell 
induction varies considerably among patients, raising the question of whether this variable 
could correlate with long-term clinical efficacy in patients undergoing PNOIT, as has been 
suggested in infection and vaccination.37 Previous studies have also demonstrated that there 
is significant heterogeneity of epitopes recognized by peanut-specific antibodies and have 
associated that with functional and clinical consequences raising and indirectly supporting 
the hypothesis that epitope diversity is an important feature of humoral response.38, 39 The 
approach taken here-- analyzing the diversity of the allergen-specific repertoire 
comprehensively and recovering and directly evaluating antibody function-- promises to 
significantly advance the capacity for studying the mechanistic consequence of clonal 
diversity and epitope specificity.
The recovered immunoglobulins from Ara h 2-specific class-switched B cells exhibited 
somatic hypermutation, consistent with affinity maturation and oligoclonality, as would be 
expected during an antigen-driven humoral response (Figure E5).23, 40 Furthermore, using 
the affinity selected Ara h 2-specific immunoglobulin heavy chain sequences to interrogate 
the NGS-derived library of memory B cell IgH repertoire, we characterized clonal groups of 
IgH sequences. These clonal groups were often present as multiple isotypes, consistent with 
an antigen-driven response that had undergone class switching. Despite their divergence 
from germline sequence, a subset of these sequences was found to be present between the 
three unrelated patients analyzed. These observations further support the possibility that 
these homologous sequences among unrelated patients may represent public clones – a 
finding only recently described in human B cell studies,41-43, though this study is somewhat 
limited by sample size. These shared clonal groups not only used the same V and J gene 
segments and had nearly identical CDR3 regions by definition; CDR1 and CDR2 sequences 
were also highly homologous. This information could inform structure-function studies to 
define critical mutations for Ara h 2 binding.
Of the affinity-selected Ara h 2-specific sequences used to identify shared Ara h 2 clonal 
groups, the IgG and IgA sequences exhibited extensive somatic hypermutation, and 
therefore, their homology does not simply reflect germline similarity. Furthermore, 
individual CDR3 repertoires have been shown to be highly unique, even between related 
individuals.44, 45 Previous work has suggested that the antibody repertoire in response to 
persistent antigen stimulation may induce additional stochastic and random nucleotide 
changes within the BCR repertoire, further increasing the likelihood of having clonal 
antibody divergence among individuals.24 These observations further support the idea that 
these homologous sequences among unrelated patients may represent public clones.
Evidence of convergent antibody signatures (i.e., ‘public clones’) such as these Ara h 2-
specific clonal groups, have recently been observed in the context of Dengue fever as well 
as influenza41, 42 and their identification here suggests several possibilities about their 
ontogeny. The most straightforward possibility is that the BCR repertoire to Ara h 2, a small 
and dominant B cell antigen in peanut allergy, is highly constrained by selective pressures 
during clonal affinity maturation and selection, leading to convergence upon these public 
clones. The other possibility is that the BCR repertoire of peanut allergic patients underwent 
other selective pressures (e.g., microbiome, other environmental exposures) that encouraged 
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similar selection of their memory B cell response, leading to similar BCR sequences and 
perhaps even an increased likelihood of peanut allergy by favoring the development of high 
affinity Ara h 2 specific antibodies.
Regardless of ontogeny, the presence of these shared clonal groups raises the possibility that 
protective antibodies induced by immunotherapy could have similar features (e.g., epitope 
specificity) between individuals and therefore play a role in effective PNOIT outcomes. 
Future studies in multicenter trials with diverse patient populations will likely be helpful in 
further defining the types and diversities of public clones, their ontogeny, and their potential 
significance in the induction of durable tolerance in PNOIT.
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Standard abbreviations
PNOIT Peanut oral immunotherapy
BCR B cell receptor
NGS next generation sequencing
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Key messages
• Ara h 2-specific circulating memory B cells are induced early and transiently in 
peanut oral immunotherapy and can be identified using a fluorescent multimer.
• Immunoglobulins from these circulating Ara h 2-specific B cells are affinity 
matured.
• Some clonal groups are shared among unrelated peanut allergic patients.
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Figure 1. Fluorescent Ara h 2 multimer production and validation
A, Four biotinylated Ara h 2 molecules (red = biotin) were conjugated to fluorescent 
streptavidin (SA). The multimer then could be used to identify B cells expressing a surface 
B-cell receptor (BCR) specific for Ara h 2 using flow cytometry. B, For multimer validation, 
basophils sensitized with serum from a peanut-allergic (black) but not a non-allergic donor 
(dotted) were specifically stained by the multimer (gray histogram represents unstained 
basophils). C, Circulating basophils from peanut allergic subjects undergoing PNOIT 
(N=19) and non-allergic subjects (N=5) were stained with and without the fluorescent Ara h 
2 multimer (*P=0.05). Fluorescence was standardized using Alexa Fluor 488 MESF beads. 
D, CD3-CD14-CD16-CD19+ B cell subpopulations were defined based on their CD27 
fluorescence. B cell subpopulations were defined as: Naïve B cells (CD19+CD27-IgM+), 
class-switched memory B cells (CD19+CD27intIgM-), and plasmablast cells 
(CD19+CD27hiIgM-). The multimer gate is determined based on the negative control 
(stained with the entire panel except for the multimer).
Patil et al. Page 15
J Allergy Clin Immunol. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 2. Peanut oral immunotherapy clinical trial
Patients aged 7-21 (N=22) with IgE-mediated peanut hypersensitivity (positive specific IgE, 
skin prick testing, and history of reaction) underwent PNOIT in a single-center, randomized 
trial (3:1, active:observational arm) using commercially available peanut flour. Patients 
recruited into the active arm underwent a one-day modified rush protocol for a maximum 
dose of 12mg, followed by a build-up period with escalating peanut doses every 2 weeks 
which included blood draws at every month (arrows), starting at 2 weeks. The build-up 
period was followed by a maintenance period of 3 months at 4000mg followed by an oral 
food challenge to assess tolerance. The 2 time points used for next generation-sequencing 
are noted using asterisks.
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Figure 3. Multimer-positive B cells and Ara h 2 immunoglobulins during the course of PNOIT
A, The frequency of multimer-positive cells was normalized to the subset (naïve, memory, 
or plasmablast) population and described as the number of cells per million subset cells. B, 
Longitudinal analysis using a generalized additive mixed non-linear model demonstrates 
that multimer-positiveclass-switched memory B cell expansion within the memory B cell 
compartment occurs transiently during early PNOIT, peaking at week 7. C, Ara h 2-specific 
IgG, IgE, IgA, and IgG4 levels were measured longitudinally during PNOIT (N=22) by 
Phadia ImmunoCAP.
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Figure 4. Single-cell antibody cloning of multimer-positive B cells
A, Individual multimer-positive CD19+ B cells were FACS sorted from 3 patients one 
month after initiation of PNOIT into a 96-well plate (sample shown above). B, 
Immunoglobulin heavy chain amplification from the 3 patients yielded of a total of 135 
heavy chains, of which 40% were IgM, 32.6% were IgG, 26.7% were IgA and <1% could 
not be classified, based on identification by primer alignment of sequences. C, The 
frequency of somatic mutations is higher in the heavy chains compared to the light chains in 
the immunoglobulins amplified from sorted multimer-positive B cells. D, In amplified 
immunoglobilin heavy chain sequences, the frequency of non-silent mutations tend to be 
higher in the complementary determining regions (CDR) as opposed to the framework (FR) 
regions in IgA and IgG sequences compared to IgM sequences, suggestive of affinity 
maturation in the IgA and IgG immunoglobulin heavy chains. E, The distribution of heavy 
chain V-J gene usage is varied in the single-cell amplified immunoglobulins. F, From the 3 
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patients, a total of 40 recombinant antibodies were produced from paired transfection of 
HEK293 cells. While none of the IgM antibodies expressed were Ara h 2-specific, 24 of the 
27 (89%) IgA or IgG antibodies were confirmed to be Ara h 2-specific by ImmunoCAP.
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Figure 5. Stereotyped Ara h 2 clones within the NGS repertoire
In each diagram, individual multimer-identified Ara h 2 sequences on the left were mapped 
to homologous sequences (same V-J gene segment with similar CDR3) within the NGS 
repertoire represented on the right. Colors on the outer left edge of the circle represent the 
subject origin of either the Ara h 2 sequence (on the left) or NGS repertoire (on the right). 
Ribbon width represents the relative frequency of the homologous sequence or clonal group, 
allowing for a relative comparison of the frequency of homologous sequences in the NGS 
repertoire to the Ara h 2 single cell sequence. Ribbon color (by the isotype of the Ara h 2 
sequence) highlights those clones shared among unrelated subjects, with gray ribbons 
showing the subject-specific clonal groups.
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Figure 6. Identity of Ara h 2 homologous sequences within the NGS repertoire to their affinity-
selected Ara h 2 single-cell sequence counterparts
A, Ara h 2 similar sequences within the NGS repertoire are shaded by their isotypes while 
the multimer-identified Ara h 2 sequences are represented as black dots. The Ara h 2 
homolgous sequences on the x-axis demonstrate strong nucleotide similarity with the 
multimer identified Ara h 2 sequences. Class-switched IgA and IgG sequences are more 
highly mutated than IgM from germline. These graphs are representative. B, The CDR 1, 2, 
and 3 regions of homologous NGS sequences from all 3 patients are aligned to a 
representative Ara h 2 affinity-selected sequence from Patient 2. Colored amino acid 
residues represent disagreements with the Ara h 2 multimer-identified sequence while 
similar residues are gray. Colors represent polarity of the amino acid residues. Asterisks 
mark amino acid substitutions from the germline sequence.
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Table 1
Demographics of patients undergoing peanut oral immunotherapy
Characteristics
Total subjects N=22
Age at enrollment 9 [7 - 15]
Gender 7 female, 15 male
Skin prick wheal at baseline 10.4 mm ± 6.1 mm
Skin prick flare at baseline 25.0 mm ± 9.0 mm
Specific IgE to Ara h 2 at baseline 113.2 kU/L (0.9-828)
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